Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China
2014年2月10日 更新者:The Hong Kong Polytechnic University
Development and Evaluation of a Life Review Program for Advanced Cancer Patients in Fuzhou, China
This study aims to develop a life review program and test its effectiveness on a sample of patients with advanced cancer patients receiving palliative care at home in Fuzhou.
研究概览
详细说明
A life review program is mainly developed based on Erickson's theory, Confucius's teaching on human development, and the empirical findings of the researcher's preliminary study and pre-pilot study.
The program covers reviewing a life for advanced cancer patients and formulating a booklet for them.
A randomized controlled trial will be adopted for evaluation of this program.
Eligible patients will be randomly assigned to the experimental group and the control group.
The subjects in the experimental group will receive a life review program for three weeks.
The outcome measure is quality of life (QOL), including domains of physical discomfort, food-related concerns, health care concerns, support, negative emotions, sense of alienation, existential distress and value of life.
Subjects' QOL will be assessed before commencement of the program (T0) and one day (T1) and three weeks (T2) after the completion of the program for all subjects in two groups.
Perceptions of the program will be elicited within three days after the program for subjects in the experimental group.Descriptive statistics will be used to analyze patients' personal information, disease related information, functional performance and QOL of advanced cancer patients.
Repeated measures ANOVA will be used to measure QOL differences in between-group, within-group and interaction effects.
Content analysis will be used to analyze the qualitative data collected.
研究类型
介入性
注册 (实际的)
80
阶段
- 第四阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Fujian
-
Fuzhou、Fujian、中国、350001
- The Fujian Hospice
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Patients who are newly admitted to the study hospice
- Patients who are suffering from cancer with metastasis made by a physician
- Patients who know their diagnosis, prognosis and therapy
- Patients' functional performance (the score of KPS) at or more than 50%
- Patients who are adults (≥18 years old)
- Patients who have no cognitive and verbal communication impairments
Exclusion Criteria:
- Patients with planned treatments, such as chemotherapy, radiotherapy or surgery
- Patients with psychiatric disorders
- Patients who live outside Fuzhou since the following-up home visit services are not extended to those areas
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:life review
a life review program includes 3-session life review and formulation of a life review book as a gift for advanced cancer patients.
|
The life review program includes reviewing a life and formalating a life booklet.
Reviewing a life consists of three weekly sessions separately addressing illness experience, adulthood life and childhood and adolescence life.
Each session lasts about 30 to 60mintues.A booklet with photos documented significant life events will be produced as a gift for the subjects.
The edition, photos and contents fo the booklet are determined by the subjects.
其他名称:
|
无干预:controlled group
the subjects in the controlled group do not receive the life review program
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
---|---|
quality of life
大体时间:three weeks and six weeks
|
three weeks and six weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Enid Kwong, PhD、School of Nursing, the Hong Kong Polytechnic University
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2009年2月1日
初级完成 (实际的)
2010年4月1日
研究完成 (实际的)
2010年6月1日
研究注册日期
首次提交
2009年8月3日
首先提交符合 QC 标准的
2009年8月3日
首次发布 (估计)
2009年8月4日
研究记录更新
最后更新发布 (估计)
2014年2月11日
上次提交的符合 QC 标准的更新
2014年2月10日
最后验证
2009年8月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
晚期癌症的临床试验
-
Advanced Bionics完全的重度至重度听力损失 | 在 Advanced Bionics HiResolution™ 仿生耳系统的成人用户中美国
-
QIAGEN Gaithersburg, Inc完全的呼吸道合胞病毒感染 | 甲型流感 | 鼻病毒 | 乙型流感 | QIAGEN ResPlex II Advanced Panel | 人类副流感病毒 1 引起的感染 | 副流感 2 型 | 3 型副流感 | 副流感 4 型 | 人类偏肺病毒 A/B | 柯萨奇病毒/埃可病毒 | B/C/E 型腺病毒 | 冠状病毒亚型 229E | 冠状病毒亚型 NL63 | 冠状病毒亚型 OC43 | 冠状病毒亚型 HKU1 | 人类博卡病毒 | Artus 流感 A/B RT-PCR 检测美国